Trajectories of metabolic risk factors during the development of type 2 diabetes in Chinese adults.

Diabetes Metab

Department of Epidemiology and Biostatistics, Ministry of Education Key Laboratory of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, China. Electronic address:

Published: September 2022

Aims: China has the largest number of adults with diabetes. Although multiple metabolic risk factors (MRFs) are implicated in the development of diabetes, it remains unclear how they progress during the development of diabetes among Chinese. We examined trajectories of multiple MRFs among Chinese and identified the critical period when drastic changes occurred during the development of diabetes.

Methods: This prospective cohort study included participants since 2006-2007 in the Kailuan study. People attended biennial examinations until 2017 with additions of new participants at each examination cycle. The time when a participant first completed the examination was served as the baseline. A total of 122,659 participants without prevalent diabetes at baseline and with complete follow-up data were included. MRFs were collected via biennial physical examinations and laboratory measures. Incident diabetes cases were identified via biennial fasting glucose tests and self-reported physician-diagnosis.

Results: During up to 12 years of follow-up, 14,922 incident diabetes cases were identified. Compared with participants who did not develop diabetes, those who developed diabetes had more adverse levels of most MRFs at baseline and during follow-up. Abrupt increases in multiple MRFs (including fasting glucose, surrogate insulin resistance indicators, lipids, systolic blood pressure, pulse pressure, heart rate, alanine aminotransferase, and C-reactive protein) were observed 3 years before the diagnosis of diabetes.

Conclusions: We identified 3 years before diabetes diagnosis as a critical period when multiple MRFs experienced drastic changes. This would have implications for early monitoring and timely prevention for individuals who experience sudden adverse progression of multiple MRFs.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diabet.2022.101348DOI Listing

Publication Analysis

Top Keywords

multiple mrfs
16
diabetes
10
metabolic risk
8
risk factors
8
diabetes chinese
8
development diabetes
8
critical period
8
drastic changes
8
incident diabetes
8
diabetes cases
8

Similar Publications

Systemic chemotherapy improves outcome of hepatocellular carcinoma patients treated with transarterial chemoembolization.

Hepatobiliary Pancreat Dis Int

November 2024

Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China. Electronic address:

Article Synopsis
  • Transarterial chemoembolization (TACE) with or without tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) is evaluated for its effectiveness as neoadjuvant therapy in hepatocellular carcinoma (HCC), focusing on the relationship between pathologic response and patient prognosis.
  • In a study involving 481 HCC patients, 15.8% achieved complete pathologic response (CPR), and 37.2% reached major pathologic response (MPR), with improved median recurrence-free survival (RFS) noted in those achieving MPR or CPR.
  • Analysis identified independent risk factors affecting recurrence-free survival, including failure to reach MPR, positive HBsAg, multiple lesions, and
View Article and Find Full Text PDF

Purpose: We explored the role of tumor size and number in the prognosis of HCC patients who underwent ablation and created a nomogram based on machine learning to predict the recurrence.

Patients And Methods: A total of 990 HCC patients who underwent transcatheter arterial chemoembolization (TACE) combined ablation at Beijing Youan Hospital from January 2014 to December 2021 were prospectively enrolled, including 478 patients with single small HCC (S-S), 209 patients with single large (≥30mm) HCC (S-L), 182 patients with multiple small HCC (M-S), and 121 patients with multiple large HCC (M-L). S-S patients were randomized in a 7:3 ratio into the training cohort (N=334) and the validation cohort (N=144).

View Article and Find Full Text PDF

Data Fusion of RGB and Depth Data with Image Enhancement.

J Imaging

March 2024

Group of Quality Assurance and Industrial Image Processing, Faculty of Mechanical Engineering, Technische Universität Ilmenau, 98693 Ilmenau, Germany.

Since 3D sensors became popular, imaged depth data are easier to obtain in the consumer sector. In applications such as defect localization on industrial objects or mass/volume estimation, precise depth data is important and, thus, benefits from the usage of multiple information sources. However, a combination of RGB images and depth images can not only improve our understanding of objects, capacitating one to gain more information about objects but also enhance data quality.

View Article and Find Full Text PDF
Article Synopsis
  • Decoding brain states using fMRI data is a hot topic, but existing methods struggle with the temporal relationships in the data due to limitations in machine learning techniques and sample organization.
  • The researchers introduced a new method called Group-DBRNN, which improves brain state decoding by using a specialized sample organization strategy and a bidirectional recurrent neural network to better capture temporal dependencies.
  • Testing on a comprehensive dataset showed that their model achieved a high accuracy of 94.7% in identifying different brain states, demonstrating its effectiveness in handling temporal dynamics and task-related differences in brain activity.
View Article and Find Full Text PDF

Membrane transporters are important determinants of drug bioavailability. Their expression and activity affect the intracellular drug concentration in leukemic cells impacting response to therapy. Pharmacogenomics represents genetic markers that reflect allele arrangement of genes encoding drug transporters associated with treatment response.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!